Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205563
http://www.fiercepharma.com/pharma/mylan-enters-concerta-generics-fray-after-fda-boots-mallinckrodt-lannett
https://www.statnews.com/pharmalot/2016/10/24/generic-fda-concerta-adhd/
https://www.pharmacompass.com/pdf/news/kremers-urban-pharms-generic-buprenorphine-hydrochloride-approved-in-us-1474551233.pdf
https://www.pharmacompass.com/pdf/news/kremers-urban-pharms-generic-potassium-chloride-approved-in-us-for-hypokalemia-1459422540.pdf
https://www.pharmacompass.com/pdf/news/kremers-urban-pharms-generic-temozolomide-approved-in-us-an-anti-cancer-chemotherapy-drug-1455705717.pdf
http://www.prnewswire.com/news-releases/lannett-announces-cost-savings-and-restructuring-actions-300213029.html
http://www.prnewswire.com/news-releases/lannett-comments-on-integration-plans-cost-reduction-initiatives-300196012.html
http://www.europeanpharmaceuticalreview.com/36962/news/industry-news/lannett-completes-acquisition-of-kremers-urban-pharmaceuticals/?
http://www.biospace.com/News/amgen-ma-speculation-heats-up-with-four-potential/398806/source=TopBreaking